March 28, 2024 S&P 500 Soars 10% in Q1, Outstrips Bullish Forecasts
March 20, 2024 Fed Grapples With Rate Decision Amid Inflation Concerns
March 19, 2024 Bank of Japan Ends Era of Negative Rates
CashFlow Hunter On Pair Trading, 3M And Iris Energy
Apple: AI Strategy To Help Fight DOJ, Kickstart Growth
Nvidia Stock Priced As If It Will Deliver Us The Moon
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice
February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?
EyePoint Pharmaceuticals (EYPT) stock forecast for 2024
Updated: March 26, 2024 (09:51)
Sector: HealthcareThe share price of EyePoint Pharmaceuticals, Inc. (EYPT) now
50/200 Day Moving Average: $25.58 / $14.69
This figure corresponds to the Average Price over the previous 50/200 days. For EyePoint Pharmaceuticals stocks, the 50-day moving average is the resistance level today.
For EyePoint Pharmaceuticals stocks, the 200-day moving average is the resistance level today.
Are you interested in EyePoint Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the EyePoint Pharmaceuticals stock price in 2024. How much will one EyePoint Pharmaceuticals share be worth in 2024? Is it worth taking profit / loss on EYPT stock now or waiting? What are analysts' forecasts for EyePoint Pharmaceuticals stock?
We forecast EyePoint Pharmaceuticals stock performance using neural networks based on historical data on EYPT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
EyePoint Pharmaceuticals, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for EyePoint Pharmaceuticals analysts is $43.67. Today 200 Day Moving Average is the support level (14.69 $). 50 Day Moving Average is the support level (25.58 $).
Historical and forecast chart of EyePoint Pharmaceuticals, Inc. stock
The chart below shows the historical price of EyePoint Pharmaceuticals stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the EYPT stock price can be found in the table below.
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
EyePoint Pharmaceuticals (EYPT) Forecast for 2024
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Apr | 19.75 | 16.75 | 22.16 | 24.39 % |
May | 21.14 | 18.97 | 23.95 | 20.79 % |
Jun | 21.74 | 19.22 | 22.98 | 16.36 % |
Jul | 19.60 | 17.77 | 20.97 | 15.27 % |
Aug | 17.47 | 16.78 | 19.73 | 14.98 % |
Sep | 20.30 | 19.18 | 21.99 | 12.80 % |
Oct | 21.03 | 19.63 | 22.27 | 11.84 % |
Nov | 20.67 | 17.96 | 23.06 | 22.13 % |
Dec | 19.61 | 17.97 | 22.40 | 19.79 % |
EyePoint Pharmaceuticals information and performance
480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US
Market capitalization of the EyePoint Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EYPT shares in the company outstanding by the market price of one share.
EBITDA of EyePoint Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
EyePoint Pharmaceuticals price target for 2024 by month
Target values for the price of one EyePoint Pharmaceuticals share for Apr 2024.
In Apr, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 24.394% volatility is expected.
Pessimistic target level: 16.75
Optimistic target level: 22.16
Target values for the price of one EyePoint Pharmaceuticals share for May 2024.
In May, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 20.794% volatility is expected.
Pessimistic target level: 18.97
Optimistic target level: 23.95
Target values for the price of one EyePoint Pharmaceuticals share for Jun 2024.
In Jun, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 16.358% volatility is expected.
Pessimistic target level: 19.22
Optimistic target level: 22.98
Target values for the price of one EyePoint Pharmaceuticals share for Jul 2024.
In Jul, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 15.267% volatility is expected.
Pessimistic target level: 17.77
Optimistic target level: 20.97
Target values for the price of one EyePoint Pharmaceuticals share for Aug 2024.
In Aug, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 14.975% volatility is expected.
Pessimistic target level: 16.78
Optimistic target level: 19.73
Target values for the price of one EyePoint Pharmaceuticals share for Sep 2024.
In Sep, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 12.800% volatility is expected.
Pessimistic target level: 19.18
Optimistic target level: 21.99
Target values for the price of one EyePoint Pharmaceuticals share for Oct 2024.
In Oct, the Positive dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 11.842% volatility is expected.
Pessimistic target level: 19.63
Optimistic target level: 22.27
Target values for the price of one EyePoint Pharmaceuticals share for Nov 2024.
In Nov, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 22.135% volatility is expected.
Pessimistic target level: 17.96
Optimistic target level: 23.06
Target values for the price of one EyePoint Pharmaceuticals share for Dec 2024.
In Dec, the Negative dynamics for EyePoint Pharmaceuticals, Inc. shares will prevail with possible monthly volatility of 19.790% volatility is expected.
Pessimistic target level: 17.97
Optimistic target level: 22.40
EyePoint Pharmaceuticals (EYPT) stock dividend
EyePoint Pharmaceuticals last paid dividends on 01/01/1970. The next scheduled payment will be on 12/09/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.